Why it matters: GLP-1 medication use is rising fast — Gallup found roughly 1 in 7 U.S. adults has tried them for weight loss, with about 1 in 9 currently using them. As these drugs normalize, conversations about weight and appearance are spilling into the workplace, creating new risks around bias, disclosure, and eating-disorder recovery.
The Problem Areas
1. Team meals and catered events. Food-centered gatherings (lunches, offsites, conferences) can be difficult for employees managing eating disorders or recovery. Reduced appetite from GLP-1 use can also prompt unhealthy comparisons ("I shouldn't eat as much as that person").
2. Comments about weight — even "compliments" Remarks like "you look great, have you lost weight?" carry risk. Employers and coworkers rarely know the real cause — a medication, illness, stress, or a health condition — and praising it assumes the change is positive.
3. Perception bias: Survey data (Sunlight.com, Oct. 2025, n=984 GLP-1 users): 39% said coworkers treated them more positively after weight loss; 28% said the same of their boss — a signal that appearance-based treatment is already happening.
What Managers Should Do
| Situation | Do | Avoid |
|---|---|---|
| Catered meetings/offsites | Offer a variety of food options without requiring anyone to explain dietary needs | Policing food choices or eliminating items to seem "sensitive" |
| Giving praise | Compliment performance, effort, or contributions | Commenting on appearance or weight, positive or negative |
| Health concerns | Route genuine concerns to a private HR conversation | Raising it in a hallway or team setting |
| Policy design | Audit reviews/promotions for appearance-based bias; train managers on weight bias | BMI-based incentives, weight-loss contests, or tying rewards to body changes |
| Supporting a struggling colleague | Direct concerned employees to HR for guidance on sensitive, private support | Attempting to diagnose or "fix" a coworker directly |
The Core Principle
Set a workplace norm: no comments on anyone's body — positive or negative. Keep policies weight-neutral and protect confidentiality around medical conditions, including GLP-1 use.